Edwards Lifesciences Lowers Tariff Impact Forecast, Keeps Gross Margin Guidance Intact

Company Sees Limited EPS Drag And Affirms Full-Year Gross Profit Margin Range

 
• By Shubham Singh
  
The company had previously forecast a $0.05 full-year tariff hit to earnings per share, but current expectations are for less than half that amount, about $0.025. (Shutterstock)

More from Strategy

More from Business